000107381 001__ 107381
000107381 005__ 20230519145345.0
000107381 0247_ $$2doi$$a10.1111/jdv.16935
000107381 0248_ $$2sideral$$a120584
000107381 037__ $$aART-2021-120584
000107381 041__ $$aeng
000107381 100__ $$aGarcía-Malinis, A.J.
000107381 245__ $$aGranuloma annulare: report of 13 patients treated with photodynamic therapy
000107381 260__ $$c2021
000107381 5060_ $$aAccess copy available to the general public$$fUnrestricted
000107381 5203_ $$aDear Editor,
Granuloma annulare (GA) is a benign in?ammatory granuloma- tous skin. Photodynamic therapy (PDT) has been described as another therapeutic option for localized GA, with a degree of recommendation B. Therefore, we have carried out a review of all patients with GA treated with PDT in our Dermatology Unit.
We performed a retrospective observational study in San Jorge Hospital (Huesca, Spain) including all patients diagnosed with GA and treated with PDT between 2007 and 2018. Diagno- sis of GA was clinical and a skin biopsy was performed if it was necessary. In all patients, methyl aminolevulinate (MAL) or aminolevulinic acid (ALA) was applied under occlusive and opa- que dressing for 3 h and illuminated with LED 635 nm (Aktilite?, Uppsala, Sweden) with a ?uence of 37 J/cm . The lesions were prepared by a soft curettage or microneedling, and some lesions did not receive any kind of prior skin preparation. Continuous variables were described using means and standard deviations. Statistical analyses were carried out using SPSS soft- ware (version 20.0; IBM Corp, Armonk, NY, USA).
Thirteen patients were included in the study (Table 1). Eleven cases (84.6%) were women and two men (15.4%), with a mean of 53 years old. Eighty-four per cent patients (n = 11) ...
000107381 540__ $$9info:eu-repo/semantics/openAccess$$aAll rights reserved$$uhttp://www.europeana.eu/rights/rr-f/
000107381 590__ $$a9.228$$b2021
000107381 591__ $$aDERMATOLOGY$$b4 / 70 = 0.057$$c2021$$dQ1$$eT1
000107381 594__ $$a9.1$$b2021
000107381 592__ $$a1.613$$b2021
000107381 593__ $$aInfectious Diseases$$c2021$$dQ1
000107381 593__ $$aDermatology$$c2021$$dQ1
000107381 655_4 $$ainfo:eu-repo/semantics/other$$vinfo:eu-repo/semantics/submittedVersion
000107381 700__ $$aGracia-Cazaña, T.
000107381 700__ $$aPlanas Linares, D.
000107381 700__ $$aAgón-Banzo, P.J.
000107381 700__ $$0(orcid)0000-0001-8034-3617$$aGilaberte, Y.$$uUniversidad de Zaragoza
000107381 7102_ $$11007$$2183$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cÁrea Dermatología
000107381 773__ $$g35, 3 (2021), e211-e214$$pJEADV, J. Eur. Acad. Dermatol. Venereol.$$tJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY$$x0926-9959
000107381 8564_ $$s314723$$uhttps://zaguan.unizar.es/record/107381/files/texto_completo.pdf$$yPreprint
000107381 8564_ $$s127107$$uhttps://zaguan.unizar.es/record/107381/files/texto_completo.jpg?subformat=icon$$xicon$$yPreprint
000107381 909CO $$ooai:zaguan.unizar.es:107381$$particulos$$pdriver
000107381 951__ $$a2023-05-18-13:20:23
000107381 980__ $$aARTICLE